Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03496701 · ClinicalTrials.gov registry record · NA
Performance of Wearers of Stenfilcon A Contact Lenses After A Refit With Test Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT03496701 is a NA study that has completed, run by CooperVision. The registered enrollment target is 77 participants.
The verdict
NCT03496701, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The aim of this study is to determine if habitual or adapted wearers of stenfilcon A control contact lenses can be refit into test lenses and be successful after one week of daily wear.
Interventions
- DEVICE Test lens
- DEVICE control lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2019-01-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03496701
The ClinicalTrials.gov registry entry for NCT03496701 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Test lens is the first listed.
NCT03496701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03496701 about?
NCT03496701 is a clinical study titled "Performance of Wearers of Stenfilcon A Contact Lenses After A Refit With Test Lenses". The aim of this study is to determine if habitual or adapted wearers of stenfilcon A control contact lenses can be refit into test lenses and be successful after one week of daily wear.
What is the current status of trial NCT03496701?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2018-04-18. Estimated completion is 2019-01-17.
What interventions are being tested in trial NCT03496701?
The interventions under investigation include: Test lens (DEVICE), control lens (DEVICE).
Who is sponsoring clinical trial NCT03496701?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.